- CORPORATE OVERVIEW
- INVESTMENT APPROACH
- GIPS COMPOSITES
- FUNDS - LUXEMBOURG
ⓒ C WORLDWIDE ASSET MANAGEMENT FONDSMAEGLERSELSKAB A/S | DAMPFAERGEVEJ 26 | DK-2100 COPENHAGEN | CVR: 78 42 05 10
C WORLDWIDE - C WORLDWIDE BIOTECHNOLOGY
|Full fund name:||C WorldWide - C WorldWide Biotechnology|
|Fund category:||Healthcare Equities|
|Security identifier (ISIN):||LU0119485372|
|Launch date:||8 November 2000|
|Management fee:||1.10% per annum|
|Benchmark:||Nasdaq Biotechnology Index®**
*There is a performance fee of 20% of the increase in the NAV, when performance exceeds 5% per annum.
**The NASDAQ Stock Market®, NASDAQ®, NASDAQ OMX®, and NASDAQ Biotechnology Index® are registered trademarks and trade names of The NASDAQ OMX Group, Inc. and are used with permission.
|Investment Manager:||C WorldWide Asset Management|
|Fund structure:||C WorldWide is an open-ended mutual investment fund ("fonds commun de placement") qualifying as an undertaking for collective investment in transferable securities pursuant to Part I of the amended Law of December 17, 2010 on undertakings for collective investment.|